Tekmira Pharmaceuticals Corporation recently announced the completion of its merger with OnCore Biopharma, Inc. The merger enables the creation of a top-industry therapeutic solutions firm committed to developing a cure to address chronic hepatitis B virus infection (HBV) ... Read more